IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.178
EU - Europa 4.339
AS - Asia 3.801
SA - Sud America 424
AF - Africa 65
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 14.822
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.058
SG - Singapore 1.657
RU - Federazione Russa 1.095
CN - Cina 970
IT - Italia 752
IE - Irlanda 533
GB - Regno Unito 434
SE - Svezia 399
UA - Ucraina 395
BR - Brasile 339
VN - Vietnam 337
TR - Turchia 293
DE - Germania 213
FR - Francia 205
IN - India 172
HK - Hong Kong 93
FI - Finlandia 89
CA - Canada 59
BD - Bangladesh 52
JP - Giappone 45
MX - Messico 40
ES - Italia 39
IQ - Iraq 39
AT - Austria 34
NL - Olanda 34
PL - Polonia 28
AR - Argentina 26
ZA - Sudafrica 26
CH - Svizzera 19
BE - Belgio 17
EC - Ecuador 16
KR - Corea 16
VE - Venezuela 13
CZ - Repubblica Ceca 12
SA - Arabia Saudita 12
CO - Colombia 11
MA - Marocco 11
PK - Pakistan 11
ID - Indonesia 10
LB - Libano 10
UZ - Uzbekistan 10
IL - Israele 9
MY - Malesia 9
IR - Iran 8
EU - Europa 7
JO - Giordania 7
KE - Kenya 7
LT - Lituania 7
PH - Filippine 7
TH - Thailandia 7
PY - Paraguay 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
GR - Grecia 5
RS - Serbia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
DK - Danimarca 4
PE - Perù 4
PT - Portogallo 4
UY - Uruguay 4
AO - Angola 3
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
HN - Honduras 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
NG - Nigeria 1
Totale 14.815
Salva come PNG Salva come JPEG
Città #
Singapore 1.221
Chandler 835
San Jose 720
Jacksonville 551
Dublin 527
Ashburn 447
Dallas 327
Dearborn 281
Beijing 271
Princeton 252
Southend 208
Chieti 162
Los Angeles 150
Nanjing 150
Izmir 142
Council Bluffs 124
Santa Clara 121
Wilmington 95
New York 90
The Dalles 90
Ho Chi Minh City 89
Hong Kong 82
Ann Arbor 79
Cambridge 74
Hanoi 70
Altamura 68
Buffalo 62
Tongling 58
Pescara 57
Moscow 53
Nanchang 48
Boardman 47
Dong Ket 42
Munich 41
Redondo Beach 41
São Paulo 41
Washington 39
Orem 36
Rome 36
Tokyo 34
Vienna 30
Kunming 27
Hebei 25
Hefei 24
Milan 24
Montreal 24
Shenyang 24
Chicago 23
Warsaw 23
Brooklyn 22
Chennai 22
Jiaxing 22
Norwalk 22
Amsterdam 21
Frankfurt am Main 21
Nuremberg 21
Woodbridge 21
Tianjin 20
Da Nang 18
Johannesburg 18
Atlanta 17
Civitanova Marche 17
Mexico City 17
Boston 16
Brussels 16
Denver 16
Houston 16
Phoenix 16
Poplar 16
Stockholm 16
Ancona 15
Baghdad 15
Teramo 15
Mumbai 14
San Francisco 14
Ankara 13
Haiphong 13
Pune 13
Falls Church 12
Shanghai 12
Toronto 12
Changsha 11
London 11
Seattle 11
Augusta 10
Kocaeli 10
Memphis 10
Palermo 10
Guangzhou 9
Helsinki 9
Manchester 9
Rio de Janeiro 9
Seoul 9
Varallo 9
Columbus 8
Ferrara 8
Zurich 8
Belo Horizonte 7
Grevenbroich 7
Jinan 7
Totale 8.796
Salva come PNG Salva come JPEG
Nome #
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 804
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 222
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 185
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 172
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 167
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 162
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 162
Colonic adenoma-associated Escherichia coli express specific phenotypes 158
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 156
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 154
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 152
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 150
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 149
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 148
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 145
In vitro microbiology studies on a new peritoneal dialysis connector 143
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 141
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 136
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 133
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 133
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 133
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 132
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 132
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 132
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 129
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 128
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 128
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 126
Development of a nanocomposite membrane based on reduced graphene (r-GO) and zeolite 13X for the removal of metal ions with bactericidal actions 126
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 125
null 125
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 124
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 124
Normal breathing releases SARS-CoV-2 into the air 123
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 122
A cystic fibrosis child with lung function decline 122
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 120
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 119
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 119
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 118
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 116
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 116
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 116
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 115
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 115
Hafnia alvei from the farm to the delivery room 115
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 114
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 114
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 113
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 113
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 112
In vivo bacterial cooperation in cystic fibrosis: exposure to Stenotrophomonas maltophilia affects Pseudomonas aeruginosa virulence in murine model of acute lung infection. 112
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 111
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 111
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 111
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 111
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 110
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 110
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 109
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 109
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 109
In vitro activity of multi-branched peptides against planktonic and biofilm cells of Pseudomonas aeruginosa from cystic fibrosis patients. 109
Isolation of colistin-resistant Hafnia alvei. 108
Antidiabetic “gliptins” affect biofilm formation by Streptococcus mutans 107
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 106
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 105
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 105
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 105
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 103
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 103
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 103
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 101
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 100
Electrochemically Synthesized Silver Nanoparticles Are Active Against Planktonic and Biofilm Cells of Pseudomonas aeruginosa and Other Cystic Fibrosis-Associated Bacterial Pathogens 99
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 99
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 99
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 99
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 99
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 97
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 97
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 95
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 95
Electrochemically synthesized silver nanoparticles are active against planktonic and biofilm cells of Pseudomonas aeruginosa and other cystic fibrosis-associated bacterial pathogens 95
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 94
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 94
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 94
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 92
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 92
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 92
Individuation and evaluation of new bacteriophages for the treatment of cystic fibrosis biofilm-related lung infections caused by Pseudomonas aeruginosa. 92
Anti-inflammatory strategies to tackle Pseudomonas aeruginosa lung infections: exploring the potential of the antimicrobial peptide lin-SB056-1 and its dendrimeric derivative 92
Comparative Proteomic Analysis of Protein Patterns of Stenotrophomonas maltophilia in Biofilm and Planktonic Lifestyles 91
Multidrug-resistant Geotrichum capitatum from a haematology ward. 91
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 91
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 91
SURFACOME CHANGES of METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN BACTERIAL GROWTH UNDERGOING USNIC TREATMENT BY PROTEOMIC APPROACH 91
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 90
Growth control of adherent-invasive Escherichia coli (AIEC) by the predator bacteria Bdellovibrio bacteriovorus: a new therapeutic approach for Crohn’s disease patients 90
Interazione in vitro tra Stenotrophomonas maltophilia e cellule epiteliali bronchiali IB3-1: implicazioni in fibrosi cistica. 89
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? 89
Totale 12.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.118
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/20252.122 119 360 245 73 54 109 108 102 283 103 256 310
2025/20265.650 364 187 544 522 570 241 946 343 1.117 455 291 70
Totale 15.488